Funding

The Proprio system integrates robotics, artificial intelligence and computer vision to simplify surgical workflow, improve accuracy and reduce radiation.

U.S. employees formed a limited liability company to raise a portion of the financing to support the launch of xvision AR technology.

Neo Medical has developed a universal surgical platform, including five instruments and fourteen implants covering most spine indications.

Funds will support commercial launch and postmarket clinical studies of Tapestry to treat Achilles tendon and ligament injuries.

The company has developed a range of spinal implants and expects to receive initial FDA clearance in May 2020.

OrthoSpin raised USD $5 million in a Series B financing for its robotic, digitally enabled external fixation system.

Gramercy Extremity Orthopedics entered into a new agreement for a $1 million revolving line of credit.

Viseon closed a USD $18 million Series B financing. Proceeds will support development and commercialization of the company's visualization and illumination technologies for minimally invasive spine surgery.

restor3D raised USD $4.4 million in equity. The company develops 3D-printed implants, and entered into a development and licensing agreement with SeaSpine in late 2019.

Embody is receiving a $2.5 million Phase II research award. Funds will support development and clinical assessment of collagen-based MICROBRACE™ ACL technology for anterior cruciate ligament repair.